Advertisement

Topics

Companies Related to "Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017" [Most Relevant Company Matches] RSS

01:29 EDT 19th September 2018 | BioPortfolio

Here are the most relevant search results for "Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017" found in our extensive corporate database of over 50,000 company records.

Showing "Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017" Companies 1–25 of 7,200+

Relevant

Salubris

Shenzhen Salubris Pharmaceuticals Co., Ltd. (Salubris) is a publicly traded, fully integrated pharmaceutical company [002294:CH]. Founded in 1998, Salubris has grown to achieve sales of >$750M USD in 2017. Salubris is headquartered in Shenzhen, China, and has over 3,800 employees working across R&D, regulatory, marketing and sales. Its marketed products in...


Intec Pharma Ltd.

Intec Pharma Ltd. is a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The Company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and s...

Landscape Structures

Since 1971, Landscape Structures Inc. has been the leading commercial playground equipment manufacturer in the world. The only major playground equipment company that is employee-owned, Landscape Structures encourages outdoor play that develops healthy kids and a sustainable world by creating innovative products that are environmentally responsible. The company's mission from day one has been to e...


Lupin Pharmaceuticals, Inc

Lupin is one of the world's largest manufacturers of drugs that combat tuberculosis,bacterial infections,and cardiovascular disease.Our portfolio of drugs, manufactured in global-scale USFDA and UKMCA approved plants,also includes NSAIDS,Cox2 inhibitors and herbal-based phytomedicines.

bioRASI

bioRASI is a full service global CRO providing optimized pipeline development TM. This strategic initiative of the Russian Academy of Sciences conducts research throughout the Americas, Europe, and Asia, and is experienced in biologicals, medical devices, and small drugs, maintaining equal balance between Pilot, Phase I/BE, and Phase II/IV studies.

PolyMedix

PolyMedix is the leader in developing biomimetics - novel small molecule, oligomer and polymer protein-mimetic drugs for membrane protein and protein:protein targets. PolyMedix has a proven computational technology platform which was used to develop its first program: a line of unique anti-infective drugs for which bacterial resistance is highly unlikely to develop. Proteins are the machinery of ...

DeuteRx, LLC

DeuteRx has pioneered ‘deuterium-enabled chiral switching’ (DECS), a revolutionary approach to improve racemic (a mixture of two mirror-image compounds or enantiomers) small molecule marketed drugs and drug candidates intended for patients across multiple therapeutic indications. The development of the single, preferred enantiomer from the parent...

Synthetic Turf Council

Based in Atlanta, the Synthetic Turf Council was founded in 2003 to promote the industry and to assist buyers and end users with the selection, use and maintenance of synthetic turf systems in sports field, golf, municipal parks, airports, landscape and residential applications. The organization is also a resource for current, credible, and independent research on the safety and environmental imp...

DeuteRx LLC

DeuteRx is pioneering ‘deuterium-enabled chiral switching’ (DECS), a revolutionary approach to improve racemic (a mixture of two mirror-image compounds or enantiomers) small molecule marketed drugs and drug candidates intended for patients across multiple therapeutic indications. Numerous drugs are still developed and marketed as racemic mixtures...

FortuneRock (China) Ltd.

FortuneRock (China) Ltd., a privately held biotechnology and biopharmaceutical company registered in Beijing. Along with its 3 wholly owned subsidiaries, Tianjin SinoBiotech Ltd., SinoBiotech (Tianjin) Ltd. and Beijing Bio-Fortune Ltd., the group is focused on the discovery, development, and commercialization of novel, patent-protected gene-based recombina...

Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction. The Company's lead drug candidate, Piclidenoson, is scheduled to enter Phase III trials in 2...

American Society of Landscape Architects (ASLA)

Founded in 1899, the American Society of Landscape Architects (ASLA) is the national professional association for landscape architects, representing more than 15,000 members in 49 professional chapters and 76 student chapters. The Society's mission is to lead, to educate, and to participate in the careful stewardship, wise planning, and artful design of ou...

Chiltern

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad range of therapeutic areas for a wide variety of clients. Chiltern has conducted trials in more than 40 countries, has 24 offices and legal entities within 20 countries, resources in 37 countries and empl...

ReadCoor, Inc.

ReadCoor is leading the next generation of omics by delivering the first panomic spatial sequencing platform to the global audience of researchers, clinicians, pharma and diagnostics companies, and ultimately patients. It is accomplishing this with Fluorescent In-Situ Sequencing (FISSEQ), a fundamental new technology, which simultaneously integrates high t...

Anderson Global Group, LLC

Anderson Global Group, LLC is a privately-held company dedicated to supplying premium ingredients to the natural products industry. With decades of industry experience as suppliers, marketers and manufacturers, the Anderson Global Group team has partnered with high end manufacturers from around the globe to give AGG customers competitive advantages in innovation, price, quality and service. The c...

Gene Network Sciences

Gene Network Sciences (GNS) is a privately held biosimulation company with offices in Ithaca, New York, and Cambridge, Massachusetts. Founded in 2000, GNS creates data-driven compound simulation models that help pharmaceutical companies improve the quality of their drug candidates. Leading the company's multi-disciplinary approach are scientists specializing in molecular biology, computer science,...

Toshiba Global Commerce Solutions, Inc.

Toshiba Global Commerce Solutions is retail’s first choice for integrated in-store solutions and is a global market share leader in retail store technology. With a global team of dedicated business partners, we deliver innovative commerce solutions that transform checkout, provide seamless consumer interactions and optimize retail operations that are ...

Syreon Corporation

Syreon is a leader in the field of Digital Medicine, the use of digital communications and advanced computing technologies for global pharmaceutical and health sciences research. This revolutionary approach to health care research links laboratory sciences, clinical trials, healthcare outcomes and disease-state management in a continuous global process independent of time or location.Syreon has cr...

The Hood Incubator

The Hood Incubator was founded in 2016 to build political and economic power for Black and Brown communities in the rapidly growing cannabis industry. The nonprofit organization fulfils its mission of increasing the participation of Black and Brown communities in the legal cannabis industry through three main areas of work: Community Organizing, Policy Adv...

Cohesity

Cohesity makes your data work for you by consolidating secondary storage silos onto a hyperconverged, web-scale data platform that spans both private and public clouds. Enterprise customers begin by radically streamlining their backup and data protection, then converge file and object services, test/dev instances, and analytic functions to provide a global...

AWAKENS, Inc.

AWAKENS is a genomic software company transforming the landscape of consumer genomics. They empower consumers with easily accessible insights of their own genome data, and diversify consumer genomics services by providing an API toolkit for existing services to provide personalized solutions tailored to each person’s genetic makeup. Founded in January...

FortuneRock (China) Co., Ltd.

FortuneRock (China) Co., Ltd., a biotechnology and biopharmaceutical company registered in Beijing. Along with its 3 subsidiaries, Tianjin SinoBiotech Ltd., SinoBiotech (Tianjin) Ltd. and Beijing Bio-Fortune Ltd., the group is focused on the discovery, development, and commercialization of novel, patent-protected gene-based recombinant protein drugs with h...

Prosidion Ltd

(OSI) Prosidion is the diabetes and obesity business group within OSI Pharmaceuticals, Inc. (NASDAQ:OSIP) dedicated to the discovery and development of novel drugs for the treatment of type 2 diabetes and obesity. (OSI) Prosidion's lead compound PSN9301 is a Dipeptidyl Peptidase IV (DP-IV) inhibitor currently in Phase II clinical trials. PSN357, a glycogen phosphorylase inhibitor, is undergoing Ph...

NAM Asia Hong Kong Co., Ltd.

CEO Teppei Nakano graduated from Keio University School of Medicine in 2017. We have been adopting IPA unexplored projects by the Ministry of Economy, Trade and Industry, which represent a large number of representatives of IT companies representing Japan, twice in 2016 and 2017, independent businesses that have been adopted by unexplored This is the NAM p...

Tosk Inc.

Tosk was founded in 1998 to discover new drugs for genetic diseases and cancer. The original technology, in part licensed from Stanford University,StealthGene and Targeted Gene Delivery technologies. In the process, Tosk discovered and perfected the Optimizing Marketed Drugs side-effect-reducing drugs.Tosk's current drug discovery and development efforts focus on applying the OMD approach to disco...


More From BioPortfolio on "Myelofibrosis Global Manufacturers Marketed Phase Drugs Landscape 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks